Related references
Note: Only part of the references are listed.The significance of CUX1 and chromosome 7 in myeloid malignancies
Matthew R. M. Jotte et al.
CURRENT OPINION IN HEMATOLOGY (2022)
Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
Melvin E. Thomas et al.
LEUKEMIA (2021)
Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms
Molly K. Imgruet et al.
BLOOD (2021)
Landscape and function of multiple mutations within individual oncogenes
Yuki Saito et al.
NATURE (2020)
ERK signalling: a master regulator of cell behaviour, life and fate
Hugo Lavoie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Identifying Epistasis in Cancer Genomes: A Delicate Affair
Joris van de Haar et al.
CELL (2019)
Distinct clinical and biological implications of CUX1 in myeloid neoplasms
Mai Aly et al.
BLOOD ADVANCES (2019)
Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS
Ningfei An et al.
BLOOD (2018)
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
Hiroyoshi Kunimoto et al.
CANCER CELL (2018)
Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations
Po-Ru Loh et al.
NATURE (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells
Xi Jin et al.
BLOOD ADVANCES (2018)
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes
Jasmine C. Wong et al.
JCI INSIGHT (2018)
JMML genomics and decisions
Charlotte M. Niemeyer
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. C. Lindsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The haploinsufficient tumor suppressor, CUX1, acts as an analog transcriptional regulator that controls target genes through distal enhancers that loop to target promoters
Robert K. Arthur et al.
NUCLEIC ACIDS RESEARCH (2017)
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia
Oliver M. Dovey et al.
BLOOD (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
Copy number alterations detected as clonal hematopoiesis of indeterminate potential
Koichi Takahashi et al.
BLOOD ADVANCES (2017)
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer
Michael R. Burgess et al.
CELL (2017)
Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy
Y. Lucy Liu et al.
BLOOD (2016)
Targeting the PI3K/Akt pathway in murine MDS/MPN driven by hyperactive Ras
J. Akutagawa et al.
LEUKEMIA (2016)
Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality
Marios Dimitriou et al.
ONCOTARGET (2016)
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz et al.
NATURE GENETICS (2015)
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia
Tiffany Y. Chang et al.
BLOOD (2014)
Preclinical efficacy of MEK inhibition in Nras-mutant AML
Michael R. Burgess et al.
BLOOD (2014)
The spectrum of somatic mutations in high-risk acute myeloid leukaemia with-7/del(7q)
Megan E. McNerney et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Inactivating CUX1 mutations promote tumorigenesis
Chi C. Wong et al.
NATURE GENETICS (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
M. Ryan Corces-Zimmerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers
Zubaidah M. Ramdzan et al.
NATURE REVIEWS CANCER (2014)
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia
Megan E. McNerney et al.
BLOOD (2013)
NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions
Jinyong Wang et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Haploinsufficiency of SAMD9L, an Endosome Fusion Facilitator, Causes Myeloid Malignancies in Mice Mimicking Human Diseases with Monosomy 7
Akiko Nagamachi et al.
CANCER CELL (2013)
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML
K. Takahashi et al.
LEUKEMIA (2013)
Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness
Qing Li et al.
NATURE (2013)
Dominant Role of Oncogene Dosage and Absence of Tumor Suppressor Activity in Nras-Driven Hematopoietic Transformation
Jin Xu et al.
CANCER DISCOVERY (2013)
Detectable clonal mosaicism from birth to old age and its relationship to cancer
Cathy C. Laurie et al.
NATURE GENETICS (2012)
Hematopoiesis and leukemogenesis in mice expressing oncogenic NrasG12D from the endogenous locus
Qing Li et al.
BLOOD (2011)
Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner
Jinyong Wang et al.
BLOOD (2011)
Cux1 and Cux2 Regulate Dendritic Branching, Spine Morphology, and Synapses of the Upper Layer Neurons of the Cortex
Beatriz Cubelos et al.
NEURON (2010)
The multiple roles of CUX1: Insights from mouse models and cell-based assays
Laurent Sansregret et al.
GENE (2008)
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
Kevin M. Haigis et al.
NATURE GENETICS (2008)
Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1
Neal I. Alcalay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Implications of NRAS mutations in AML:: a study of 2502 patients
Ulrike Bacher et al.
BLOOD (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7
LE Side et al.
GENES CHROMOSOMES & CANCER (2004)
Cancer genes and the pathways they control
B Vogelstein et al.
NATURE MEDICINE (2004)
Molecular signatures of proliferation and quiescence in hematopoietic stem cells
TA Venezia et al.
PLOS BIOLOGY (2004)
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice
SC Kogan et al.
BLOOD (2002)
Studies on the role of Cux1 in regulation of the onset of joint formation in the developing limb
G Lizarraga et al.
DEVELOPMENTAL BIOLOGY (2002)
Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice
AM Sinclair et al.
BLOOD (2001)
Share Paper
